您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Kojic acid
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Kojic acid
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Kojic acid图片
CAS NO:501-30-4
包装与价格:
包装价格(元)
20 mg电议
1 mL*10 mM(in DMSO)电议

产品介绍
Kojic acid 是 Aspergillus oryzae产生的一种真菌代谢物,用作抗氧化剂和防辐射剂,可抑制酪氨酸酶。

产品描述

Kojic acid is a fungal metabolite that inhibits tyrosinase, an enzyme involved in melanin synthesis, with an IC50 value of 30.6 μM for mushroom tyrosinase.

体外活性

Kojic acid(KA) (50 μg/mL) was found to decrease the growth by 62% (IC50 34 μg/mL) and 79% (IC50 27.84 μg/mL) of promastigotes and amastigotes in vitro, respectively. KA-treated amastigotes showed the presence of vesicles bodies into the flagellar pocket, and an intense intracellular vacuolization and swelling of the mitochondrion. During the in vitro interaction of parasites and the host cell, KA reverses the superoxide anions (O2-) inhibitory mechanism promoted by parasite[1].

体内活性

4 weeks after KA-topical formulation treatment of infected animals, a healing process was observed with a high production of collagen fibers and a decrease in parasite burden. The great potential of KA as an anti-leishmanial compound[1].

细胞实验

Amazonensis promastigotes (10^6 parasites/mL) were inoculated in a 24-well plate containing RPMI medium supplemented with 10% inactivated fetal bovine serum treated with different concentrations of KA and incubated at 25 °C for 5 days without medium replacement. Every 24 h after treatment, aliquots were harvested and the effect of Kojic acid on promastigotes growth was evaluated using a Neubauer chamber and compared with untreated parasites culture. The cultures were performed in triplicate[1].

动物实验

Animals (eight-week-old female Golden hamsters) were infected with 10^6 of L. amazonensis promastigotes/mL during the stationary growth phase with a maximum volume of 0.2 mL on both hind paws.?Animals were separated in 3 groups: untreated (n?=?5);?KA-treated 100 mg/kg/day (n?=?5) and KA vehicle (n?=?5).?KA topical formulation treatment was initiated after 5 weeks of infection.?The KA formulation and vehicle was applied topically to all lesions once daily for 4 weeks.?Control groups were also maintained in parallel.?During the treatment period, the lesion size was measured weekly using a caliper.?Width and height of both hind paws were used to calculate the lesion area (mm^2)[1].

Cas No.

501-30-4

分子式

C6H6O4

分子量

142.11

储存和溶解度

DMSO:28 mg/mL (197.03 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years